Tuula Simell

7.8k total citations · 3 hit papers
54 papers, 5.3k citations indexed

About

Tuula Simell is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Tuula Simell has authored 54 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Genetics, 36 papers in Endocrinology, Diabetes and Metabolism and 21 papers in Surgery. Recurrent topics in Tuula Simell's work include Diabetes and associated disorders (44 papers), Diabetes Management and Research (34 papers) and Pancreatic function and diabetes (20 papers). Tuula Simell is often cited by papers focused on Diabetes and associated disorders (44 papers), Diabetes Management and Research (34 papers) and Pancreatic function and diabetes (20 papers). Tuula Simell collaborates with scholars based in Finland, United States and Sweden. Tuula Simell's co-authors include Olli Simell, Mikael Knip, Jorma Ilonen, Riitta Veijola, Heikki Hyöty, Antti Kupila, Sari Korhonen, Jennifer C. Drew, Desmond Schatz and Eric W. Triplett and has published in prestigious journals such as The Lancet, JAMA and Journal of Biological Chemistry.

In The Last Decade

Tuula Simell

54 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children

2013 833 citations Anette G. Ziegler, Marian Rewers et al. JAMA profile →
Toward defining the autoimmune microbiome for type 1 diabetes

2010 618 citations Adriana Giongo, K.A. Gano et al. profile →
Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes

2011 617 citations Christopher T. Brown, Austin G. Davis‐Richardson et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tuula Simell Finland	29	3.4k	2.5k	2.3k	1.4k	557	54	5.3k
Anette‐G. Ziegler Germany	48	5.6k 1.6×	4.2k 1.7×	4.3k 1.9×	652 0.5×	859 1.5×	144	7.9k
Taina Härkönen Finland	26	1.4k 0.4×	873 0.4×	836 0.4×	1.2k 0.8×	251 0.5×	80	3.0k
Riccardo Bonfanti Italy	34	1.7k 0.5×	1.4k 0.6×	2.2k 1.0×	518 0.4×	1.5k 2.7×	156	4.6k
Heli Siljander Finland	23	1.2k 0.3×	844 0.3×	821 0.4×	1.3k 0.9×	161 0.3×	48	3.1k
Riitta Veijola Finland	55	7.1k 2.1×	5.2k 2.1×	5.1k 2.2×	2.0k 1.4×	748 1.3×	280	12.2k
B. Vialettes France	32	1.1k 0.3×	1.5k 0.6×	1.1k 0.5×	1.5k 1.1×	95 0.2×	173	4.3k
Denis Franchimont Belgium	38	2.2k 0.6×	488 0.2×	1.3k 0.5×	964 0.7×	471 0.8×	115	6.2k
Emanuel Lebenthal United States	37	1.1k 0.3×	422 0.2×	1.5k 0.7×	601 0.4×	466 0.8×	259	5.1k
Eran Israeli Israel	32	1.0k 0.3×	522 0.2×	724 0.3×	529 0.4×	294 0.5×	96	3.5k
William R. Treem United States	36	1.2k 0.4×	253 0.1×	1.3k 0.5×	1.0k 0.7×	721 1.3×	140	4.5k

Countries citing papers authored by Tuula Simell

Since Specialization

Citations

This map shows the geographic impact of Tuula Simell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuula Simell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuula Simell more than expected).

Fields of papers citing papers by Tuula Simell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuula Simell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuula Simell. The network helps show where Tuula Simell may publish in the future.

Co-authorship network of co-authors of Tuula Simell

This figure shows the co-authorship network connecting the top 25 collaborators of Tuula Simell. A scholar is included among the top collaborators of Tuula Simell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuula Simell. Tuula Simell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Helminen, Olli, Jaakko Matomäki, Juha Mykkänen, et al.. (2015). Reduced β-cell function in early preclinical type 1 diabetes. European Journal of Endocrinology. 174(3). 251–259. 36 indexed citations

Laitinen, Olli H., Hanna Honkanen, Sami Oikarinen, et al.. (2014). Coxsackievirus B1 Is Associated With Induction of beta-Cell Autoimmunity That Portends Type 1 Diabetes. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 12 indexed citations

Ziegler, Anette G., Marian Rewers, Olli Simell, et al.. (2013). Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children. JAMA. 309(23). 2473–2473. 833 indexed citations breakdown →

Brown, Christopher T., Austin G. Davis‐Richardson, Adriana Giongo, et al.. (2011). Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes. PLoS ONE. 6(10). e25792–e25792. 617 indexed citations breakdown →

Elo, Laura L., Juha Mykkänen, Satu Simell, et al.. (2010). Early suppression of immune response pathways characterizes children with prediabetes in genome-wide gene expression profiling. Journal of Autoimmunity. 35(1). 70–76. 29 indexed citations

Siljander, Heli, Satu Simell, Anne Hekkala, et al.. (2009). Predictive Characteristics of Diabetes-Associated Autoantibodies Among Children With HLA-Conferred Disease Susceptibility in the General Population. Diabetes. 58(12). 2835–2842. 103 indexed citations

Simell, Satu, Sanna Hoppu, Anne Hekkala, et al.. (2007). Fate of Five Celiac Disease-Associated Antibodies During Normal Diet in Genetically At-Risk Children Observed from Birth in a Natural History Study. The American Journal of Gastroenterology. 102(9). 2026–2035. 73 indexed citations

Korhonen, Tapio, Tuula Simell, Päivi Keskinen, et al.. (2006). Parental Reactions to Information About Increased Genetic Risk of Type 1 Diabetes Mellitus in Infants. Archives of Pediatrics and Adolescent Medicine. 160(11). 1131–1131. 16 indexed citations

Simell, Tuula, et al.. (2006). The Effects of Type 1 Diabetes and its Long-Term Complications on Physical and Mental Health Status. PharmacoEconomics. 24(6). 559–569. 4 indexed citations

10.

Vuorinen, Pauli, Ari Kuusisto, Satu Simell, et al.. (2006). Time‐Resolved Fluorescence Imaging of Islet Cell Autoantibodies. Annals of the New York Academy of Sciences. 1079(1). 226–228. 2 indexed citations

11.

Vuorinen, Pauli, Satu Simell, Tuula Simell, et al.. (2005). TIME-RESOLVED FLUORESCENCE IMAGING OF ISLET CELL AUTOANTIBODIES DURING PROGRESSION TO TYPE 1 DIABETES IN THE PROSPECTIVE DIPP COHORT. Endocrine Journal. 52. 59. 1 indexed citations

12.

Kimpimäki, Teija, Antti Kupila, Sari Korhonen, et al.. (2003). Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study. Diabetologia. 46(1). 65–70. 14 indexed citations

13.

Kupila, Antti, Jorma Sipilä, Päivi Keskinen, et al.. (2003). Intranasally administered insulin intended for prevention of type 1 diabetes—a safety study in healthy adults. Diabetes/Metabolism Research and Reviews. 19(5). 415–420. 51 indexed citations

14.

Keskinen, Päivi, Sari Korhonen, Antti Kupila, et al.. (2002). First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes. Diabetologia. 45(12). 1639–1648. 58 indexed citations

15.

Hämäläinen, Anu‐Maaria, Jorma Ilonen, Olli Simell, et al.. (2002). Prevalence and fate of type 1 diabetes‐associated autoantibodies in cord blood samples from newborn infants of non‐diabetic mothers. Diabetes/Metabolism Research and Reviews. 18(1). 57–63. 14 indexed citations

16.

Hämäläinen, H., et al.. (2002). Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications. Quality of Life Research. 11(5). 427–436. 78 indexed citations

17.

Kupila, Antti, P Muona, Tuula Simell, et al.. (2001). Feasibility of genetic and immunological prediction of Type I diabetes in a population-based birth cohort. Diabetologia. 44(3). 290–297. 268 indexed citations

18.

Simell, Tuula, et al.. (1998). Costs of predicting IDDM. Diabetologia. 41(1). 79–85. 39 indexed citations

19.

Simell, Tuula, et al.. (1996). Costs of Insulin-Dependent Diabetes Mellitus. PharmacoEconomics. 9(1). 24–38. 19 indexed citations

20.

Simell, Tuula, Olli Simell, & Harri Sintonen. (1993). The First Two Years of Type 1 Diabetes in Children: Length of the Initial Hospital Stay Affects Costs But Not Effectiveness of Care. Diabetic Medicine. 10(9). 855–862. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact